
Navidea Biopharmaceuticals NAVB
Quarterly report 2023-Q3
added 05-23-2026
Navidea Biopharmaceuticals Total Inventories 2011-2026 | NAVB
Annual Total Inventories Navidea Biopharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 427 K | 151 K | 170 K | - | - | - | 96.2 K | 653 K | 932 K | 2.23 M | 298 K | 822 K | 632 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.23 M | 96.2 K | 641 K |
Quarterly Total Inventories Navidea Biopharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 461 K | 461 K | 461 K | 427 K | 194 K | 316 K | 323 K | 151 K | 179 K | 179 K | 166 K | 170 K | 170 K | 170 K | 170 K | - | - | - | - | - | - | - | - | - | 96.2 K | 96.2 K | 748 | 96.2 K | 805 K | 770 K | 899 K | 653 K | 877 K | 1.2 M | 572 K | 932 K | 1.12 M | 1.91 M | 2.11 M | 2.23 M | 2.04 M | 1.33 M | 867 K | 298 K | 641 K | 918 K | 918 K | 822 K | 844 K | 1.64 M | 822 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.23 M | 748 | 703 K |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
653 K | - | 1.35 % | $ 17.8 M | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.42 | - | $ 166 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
21.2 M | - | - | $ 2.18 B | ||
|
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.38 M | - | -4.36 % | $ 27 M | ||
|
Anika Therapeutics
ANIK
|
18.8 M | $ 14.57 | -0.21 % | $ 209 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 22.79 | 5.8 % | $ 2.9 B |